416 related articles for article (PubMed ID: 16443603)
1. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.
Cripps D; Thomas SN; Jeng Y; Yang F; Davies P; Yang AJ
J Biol Chem; 2006 Apr; 281(16):10825-38. PubMed ID: 16443603
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational modifications of tau in paired helical filaments.
Morishima M; Ihara Y
Dementia; 1994; 5(5):282-8. PubMed ID: 7951685
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
4. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody PHF-9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments.
Zemlan FP; Dean GE
J Neurosci Res; 1996 Oct; 46(1):90-7. PubMed ID: 8892109
[TBL] [Abstract][Full Text] [Related]
6. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.
Hanger DP; Betts JC; Loviny TL; Blackstock WP; Anderton BH
J Neurochem; 1998 Dec; 71(6):2465-76. PubMed ID: 9832145
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
8. Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.
Thomas SN; Funk KE; Wan Y; Liao Z; Davies P; Kuret J; Yang AJ
Acta Neuropathol; 2012 Jan; 123(1):105-17. PubMed ID: 22033876
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
10. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Weaver CL; Espinoza M; Kress Y; Davies P
Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microtubule-associated protein tau glycation in paired helical filaments.
Ledesma MD; Bonay P; Colaço C; Avila J
J Biol Chem; 1994 Aug; 269(34):21614-9. PubMed ID: 8063802
[TBL] [Abstract][Full Text] [Related]
12. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
[TBL] [Abstract][Full Text] [Related]
14. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
[TBL] [Abstract][Full Text] [Related]
15. Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly.
Hoffmann R; Dawson NF; Wade JD; Otvös L
J Pept Res; 1997 Aug; 50(2):132-42. PubMed ID: 9273897
[TBL] [Abstract][Full Text] [Related]
16. Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filament-tau.
Liu WK; Dickson DW; Yen SH
J Neurochem; 1994 Mar; 62(3):1055-61. PubMed ID: 7509372
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
Wang JZ; Grundke-Iqbal I; Iqbal K
Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
[TBL] [Abstract][Full Text] [Related]
18. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
19. Locations and immunoreactivities of phosphorylation sites on bovine and porcine tau proteins and a PHF-tau fragment.
Poulter L; Barratt D; Scott CW; Caputo CB
J Biol Chem; 1993 May; 268(13):9636-44. PubMed ID: 8486651
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase.
Jicha GA; O'Donnell A; Weaver C; Angeletti R; Davies P
J Neurochem; 1999 Jan; 72(1):214-24. PubMed ID: 9886072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
